Last reviewed · How we verify
Inactivated trivalent influenza vaccine — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
Inactivated trivalent influenza vaccine (Inactivated trivalent influenza vaccine) — Advagene Biopharma Co. Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Inactivated trivalent influenza vaccine TARGET | Inactivated trivalent influenza vaccine | Advagene Biopharma Co. Ltd. | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Inactivated trivalent influenza vaccine CI watch — RSS
- Inactivated trivalent influenza vaccine CI watch — Atom
- Inactivated trivalent influenza vaccine CI watch — JSON
- Inactivated trivalent influenza vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Inactivated trivalent influenza vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/inactivated-trivalent-influenza-vaccine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab